Search research articles
Contact Us
Filters
Showing results (481-490 of 638) with videos related to
Page
of 64
Sort By:
Acta Neurochirurgica
|
February 26, 2013
Visualization of angiographical arteriovenous shunting in perisylvian glioblastomas
A Yoshikawa, M Nakada, D Kita, et al.
The American Journal of Gastroenterology
|
January 4, 2024
Natural Histories and Disease Complications in a Cohort of 151 Children With Gastric or Duodenal Eosinophilia
Laura A Quinn, Cassandra Burger, Brian Nguyen, et al.
Clinical Pharmacology and Therapeutics
|
May 26, 1999
CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans
T Furuta, K Ohashi, K Kosuge, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 16, 2004
Association of Schatzki ring with eosinophilic esophagitis in children
Samuel Nurko, Jonathan E Teitelbaum, Khaled Husain, et al.
Allergy
|
December 8, 2016
Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis
E N McNamee, K A Biette, J Hammer, et al.
The Journal of Experimental Medicine
|
May 9, 2001
Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia
G T Furuta, J R Turner, C T Taylor, et al.
The American Journal of Gastroenterology
|
September 6, 2022
Provider Beliefs, Practices, and Perceived Barriers to Dietary Elimination Therapy in Eosinophilic Esophagitis
Joy W Chang, Kara Kliewer, David A Katzka, et al.
Alimentary Pharmacology & Therapeutics
|
June 20, 2018
High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication
T Furuta, S Baba, M Yamade, et al.
Alimentary Pharmacology & Therapeutics
|
August 14, 2012
Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype
M Sugimoto, N Shirai, M Nishino, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 2024
The MicroRNA miR-223 Constrains Colitis-associated Tumorigenesis by Limiting Myeloid Cell Infiltration and Chemokine Expression
Ciara L Flynn, Gary E Markey, Viola Neudecker, et al.
Page
of 64
Search research articles
Search
Showing results (481-490 of 638) with videos related to
Sort By:
Page
of 64
Acta Neurochirurgica
|
February 26, 2013
Visualization of angiographical arteriovenous shunting in perisylvian glioblastomas
A Yoshikawa, M Nakada, D Kita, et al.
The American Journal of Gastroenterology
|
January 4, 2024
Natural Histories and Disease Complications in a Cohort of 151 Children With Gastric or Duodenal Eosinophilia
Laura A Quinn, Cassandra Burger, Brian Nguyen, et al.
Clinical Pharmacology and Therapeutics
|
May 26, 1999
CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans
T Furuta, K Ohashi, K Kosuge, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 16, 2004
Association of Schatzki ring with eosinophilic esophagitis in children
Samuel Nurko, Jonathan E Teitelbaum, Khaled Husain, et al.
Allergy
|
December 8, 2016
Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis
E N McNamee, K A Biette, J Hammer, et al.
The Journal of Experimental Medicine
|
May 9, 2001
Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia
G T Furuta, J R Turner, C T Taylor, et al.
The American Journal of Gastroenterology
|
September 6, 2022
Provider Beliefs, Practices, and Perceived Barriers to Dietary Elimination Therapy in Eosinophilic Esophagitis
Joy W Chang, Kara Kliewer, David A Katzka, et al.
Alimentary Pharmacology & Therapeutics
|
June 20, 2018
High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication
T Furuta, S Baba, M Yamade, et al.
Alimentary Pharmacology & Therapeutics
|
August 14, 2012
Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype
M Sugimoto, N Shirai, M Nishino, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 1, 2024
The MicroRNA miR-223 Constrains Colitis-associated Tumorigenesis by Limiting Myeloid Cell Infiltration and Chemokine Expression
Ciara L Flynn, Gary E Markey, Viola Neudecker, et al.
Page
of 64